Sinopharm Group Co Ltd

XMUN:X2S

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is X2S's stock price target?

Price Target

2.6 EUR

According to Wall Street analysts, the average 1-year price target for X2S is 2.6 EUR with a low forecast of 1.93 EUR and a high forecast of 3.182 EUR.

What is the Revenue forecast for Sinopharm Group Co Ltd?

Projected CAGR

5%

Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 5%.

What is the Gross Profit forecast for Sinopharm Group Co Ltd?

Projected CAGR

9%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 9%.

What is the Operating Income forecast for Sinopharm Group Co Ltd?

Projected CAGR

9%

Over the last 14 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 9%.

What is the Pre-Tax Income forecast for Sinopharm Group Co Ltd?

Projected CAGR

10%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 10%.

What is the Net Income forecast for Sinopharm Group Co Ltd?

Projected CAGR

10%

Over the last 14 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 10%.